Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR7 | P34969 | 2/20 | 0.67 |
| ▸ | HTR6 | P50406 | 1/20 | 0.67 |
| ▸ | ADORA2B | P29275 | 4/20 | 0.66 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.66 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.66 |
| ▸ | TSHR | P16473 | 2/20 | 0.65 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.61 |
| ▸ | HTR1A | P08908 | 4/20 | 0.58 |
| ▸ | CHRM1 | P11229 | 3/20 | 0.58 |
| ▸ | DRD2 | P14416 | 3/20 | 0.58 |
| ▸ | ADRA1D | P25100 | 3/20 | 0.58 |
| ▸ | ADRA1A | P35348 | 3/20 | 0.58 |
| ▸ | ADRA1B | P35368 | 3/20 | 0.58 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.57 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.55 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.55 |
| ▸ | USP2 | O75604 | 3/20 | 0.55 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.55 |
| ▸ | XBP1 | P17861 | 1/20 | 0.54 |
| ▸ | HTT | P42858 | 2/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10895834 | 0.92 | TSHR (0.72) | HTR7HTR6ADORA2BSMN1; SMN2RXFP1 | |
| SCHEMBL684347 | 0.91 | LMNA (0.67) | HTR7HTR6ADORA2BSMN1; SMN2RXFP1 | |
| SCHEMBL684342 | 0.90 | SMN1; SMN2 (0.70) | HTR7HTR6ADORA2BSMN1; SMN2RXFP1 | |
| SCHEMBL4461767 | 0.90 | ADORA2B (0.73) | HTR7HTR6ADORA2BSMN1; SMN2RXFP1 | |
| SCHEMBL684013 | 0.90 | HTR1A (0.69) | HTR7HTR6ADORA2BSMN1; SMN2RXFP1 | |
| SCHEMBL10896398 | 0.89 | LMNA (0.67) | HTR7HTR6ADORA2BSMN1; SMN2RXFP1 | |
| SCHEMBL10896463 | 0.88 | RXFP1 (0.60) | HTR7HTR6ADORA2BSMN1; SMN2RXFP1 | |
| SCHEMBL684338 | 0.88 | HTR7 (0.60) | HTR7HTR6ADORA2BSMN1; SMN2RXFP1 | |
| SCHEMBL10896210 | 0.88 | HTR1A (0.67) | HTR7HTR6ADORA2BSMN1; SMN2RXFP1 | |
| SCHEMBL684348 | 0.87 | SMN1; SMN2 (0.69) | HTR7HTR6ADORA2BSMN1; SMN2RXFP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110269717-A1 | NEUROGENESIS BY MODULATING ANGIOTENSIN | BRAINCELLS INC. (US) | 2011-11-03 | — | — | US | disclosed |
| US-4599414-A | ANTHISTAMINES, VASODILATORS | EISAI CO., LTD. (JP) | 1986-07-08 | — | — | US | disclosed |
| EP-0023350-A1 | Theophylline derivatives, a process for the preparation of the same and a therapeutical composition | Eisai Co., Ltd. (JP) | 1981-02-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110269717-A1 | NEUROGENESIS BY MODULATING ANGIOTENSIN | NGF, DCX, BDNF | HTR7 1398/4885HTR6 683/4885ADORA2B 786/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.